Aim: The aim of this study was to investigate the effects of 4 consecutive simulated night shifts on glucose homeostasis, mitochondrial function and central and peripheral rhythmicities compared with a simulated day shift schedule. Methods: Seventeen healthy adults (8M:9F) matched for sleep, physical activity and dietary/fat intake participated in this study (night shift work n = 9; day shift work n = 8). Glucose tolerance and insulin sensitivity before and after 4 nights of shift work were measured by an intravenous glucose tolerance test and a hyperinsulinaemic euglycaemic clamp respectively. Muscles biopsies were obtained to determine insulin signalling and mitochondrial function. Central and peripheral rhythmicities were assessed by measuring salivary melatonin and expression of circadian genes from hair samples respectively. Results: Fasting plasma glucose increased (4.4 AE 0.1 vs. 4.6 AE 0.1 mmol L À1 ; P = .001) and insulin sensitivity decreased (25 AE 7%, P < .05) following the night shift, with no changes following the day shift. Night shift work had no effect on skeletal muscle protein expression (PGC1a, UCP3, TFAM and mitochondria Complex II-V) or insulin-stimulated pAkt Ser473, pTBC1D4Ser318 and pTBC1D4Thr642. Importantly, the metabolic changes after simulated night shifts occurred despite no changes in the timing of melatonin rhythmicity or hair follicle cell clock gene expression across the wake period (Per3, Per1, Nr1d1 and Nr1d2). Conclusion: Only 4 days of simulated night shift work in healthy adults is sufficient to reduce insulin sensitivity which would be expected to increase the risk of T2D.
| INTRODUCTION
Exposure to shift work is common with more than 18% of the Australian workforce working outside the "normal" working hours of 0800 hour to 1800 hour. 1 Shift workers have more health problems even after controlling for lifestyle, body composition and socioeconomic status. [2] [3] [4] Indeed, shift work increases all-cause mortality 5 and is an independent risk factor for insulin resistance, type 2 diabetes (T2D) and metabolic syndrome 6 .
Disruption to hormone and sleep rhythms, eating patterns and light exposure occur during shift work. Sleep is effected by shift work, 7, 8 due, in part, to the failure to shift the circadian rhythm of sleep to match the work schedule. However, it is unresolved whether the increased insulin resistance associated with shift work is due to changes in circadian rhythmicity per se and/or sleep patterns 9 or to lifestyle changes that often accompany shift work, such as meal timing or food choices.
Shift work may also change metabolism through skeletal muscle mitochondrial disturbances. The production of reactive oxygen species (ROS) in mitochondria occurs in a circadian manner, 10 and increases in skeletal muscle ROS production 11 and mitochondrial dysfunction are associated with insulin resistance. 12 While a recent study investigated day-night rhythmicity in human skeletal muscle oxidative capacity 13 , to date, the impact of shift work on skeletal muscle mitochondrial function and ROS production has not been directly investigated. In addition, muscle changes at mitochondrial level can also affect insulin sensitivity, but no previous study has examined the link between short-term shift work and skeletal mitochondria and insulin sensitivity in healthy humans.
Therefore, we investigated the effect of 4 consecutive simulated night shifts on glucose homeostasis, mitochondrial function and central and peripheral rhythmicities compared with a simulated day shift schedule (Figure 1 ). To minimize potential confounding effects, all the participants were provided with the same sleep opportunity (9 hours).
F I G U R E 1 Schematic of the trial design for the day shift (left panel) and night shift participants (right panel). The black bars indicate the times of the sleep opportunities. The vertical hashed bars indicate the times of day when the participants were permitted to briefly leave the facility, to simulate a commute to and from work. The gap between stage 1 and stage 2 ranged from 2.6 AE 1.2 days to 1.8 AE 0.5 days for the day shift and night shift participants respectively. IVGTT = intravenous glucose tolerance test. HEC = hyperinsulinaemic euglycaemic clamp (muscle biopsies were obtained before the commencement and immediately before the end of each HEC). A indicates the approx time of arrival at the facility, L indicates when they left the facility, and M indicates the meal and snack opportunities Physical activity level was controlled before and during the study, and participants maintained their habitual dietary preferences and intake during the study. To simulate travel to and from work, participants left the controlled conditions of the laboratory to walk in daylight for 30 minutes before and after each shift. This was expected to prevent changes in the phase of central circadian rhythms as our previous field study indicated no entrainment to 12-hour night shifts. 14 In addition, participants used a driving simulator before and after each shift to simulate commuting and prepared their own normal meals. We hypothesized that such night shift work simulation would reduce whole-body insulin sensitivity and skeletal muscle insulin signalling, reduce skeletal muscle mitochondrial respiration and increase mitochondrial ROS in the absence of either significant sleep debt or changes in rhythmicity or diet.
| RESULTS
There were no differences between the groups in age, gender balance, initial body weight, height, body mass index, Screening morningness/eveningness (MEQ) score, melatonin onset (MOn) or systolic and diastolic blood pressures (Table 1) . Neither body weight nor the blood pressure changed across the study (Table 1) .
| Fasting glucose, insulin and leptin
Fasting blood glucose and insulin did not vary (P > .05) with the day of testing (between the IVGTT and the HEC).
Fasting glucose was unchanged after the day shift (4.6 AE 0.2 vs 4.5 AE 0.1 mmol L À1 ; P > .05), but higher after the night shift (4.4 AE 0.1 vs 4.6 AE 0.1 mmol L À1 ; P = .001). Fasting insulin was not affected by shift work ( Figure 2 ). Plasma leptin levels obtained prior to the IVGTT did not change following either the day or night shifts (Table S2) .
| Intravenous glucose tolerance test
The glucose AUC was unchanged following the day shift (P > .05) but increased 13.7% following the night shift (P = .008; Figure 2 ). The insulin AUC was not different between the groups before shift work and did not change with shift work in either group (Figure 2 ).
| Hyperinsulinaemic euglycaemic clamp
Paired data were only available from 5 day shifts and 8 night shift participants. Three day shift participants and 1 night shift participant were excluded for different reasons.
One day shift participant became unwell and vomited during the clamp; in another, the target glucose level of 4.8-5.2 mmol L À1 during the clamp was not achieved, while the third was diagnosed with insulin resistance after analysis of insulin levels post-study. For 1 night shift participant, there were technical problems with the glucose analyser during the clamp. Pre-shift glucose infusion rate (GIR) was not different between the 2 groups ( Figure 3 , Figure S1 ); however, it decreased following the night shift (P = .005). Insulin sensitivity (M value; glucose infusion rate / insulin concentration during the last 30 minutes) decreased following the night shift (À25.6 AE 7.4%; P = .03) but not the day shift (P > .05) ( Figure 3 ). 
| Skeletal muscle insulin signalling
Phosphorylated Akt Ser473, TBC1D4 Ser318 and TBC1D4 Thr642 during the HEC increased similarly in both groups before and after shift work ( Figure 4 ).
| Skeletal muscle mitochondrial respiration
Muscle protein expression of PGC1a, UCP3, TFAM and Complex II-V did not change in response to either the day or night shifts (Table S3 ). There was no effect (P > .05) of day or night shifts on skeletal muscle mitochondrial respiration ( Figure 5 The data for 1 participant in each group were excluded from analysis for technical reasons with the respirometer (day shift n = 6; night shift, n = 8). Following night shifts, the ROS emission (per mg muscle wet weight) was significantly reduced in Complex I+II Leak (P = .04; Figure 5 ) with no other changes observed.
| Dietary intake
There was no significant difference in dietary intake between the groups prior to entry into the study (P > .05, Figure 6 ). During the study, dietary energy, protein, total and saturated fat, available carbohydrates (starch and soluble sugars) and sugars during the shifts were similar in both groups ( Figure 6 ). Those on night shift consumed more energy in the first meal opportunity during their F I G U R E 2 Glucose tolerance of the subjects in the night shift protocol was significantly impaired compared to the subjects in the day shift protocol. Blood glucose (mmol L
À1
) and plasma insulin (lU mL
) measured before and after a bolus injection of glucose (0.3 g kg
) into participants (A,C) before ( ) and after ( ) the day shift (mean AE SEM; N = 7) and (B,D) before ( ) and after ( ) the night shift (N = 9) and the percentage change (mean AE SEM) in the glucose (E) and insulin (F) AUC for the day ( ) and night ( ) shift participants. Data were compared by 2-way repeated measures ANOVA. Note that some SEM bars are obscured by the symbols. * P < .05 vs Day shift "work period" at 2400 hour (2021 AE 248 kJ) than those on day shift at 1000 hour (1349 AE 90 kJ), and this was reversed at the second "work period" meal opportunities for night shift participants at 0300 hour and day shift participants at 1300 hour ( Figure S2 ). With respect to macronutrients, protein intake was decreased in both groups during the study compared with pre-study (P = .04) whereas other components did not change ( Figure 6 ).
| Melatonin rhythms
The onset of melatonin occurred after the last sample collection (2200 hour) on the night before the trial commenced in 6 of 8 day shift participants, and this pattern continued throughout the study. In the morning, the melatonin offset (MOff) occurred around 0800 hour throughout the study (Figures S4 and S5, Table S4 ). In the night shift group, the onset of melatonin occurred after 2200 hour in 6 of 9 of the participants prior to commencement of the shifts. During the night shifts, melatonin was secreted and the MOn was delayed by approx 1.6 hours between day 3 and day 7 (P = .02; Figures S4 and S5 ). There were no changes in the MOff times across the study for the night shift participants or between the 2 shift schedules. insulin signal transduction proteins in skeletal muscle. Representative blots and Western blot analysis of pAkt Ser473, pTBC1D4 Ser318 and pTBC1D4 Thr642 protein relative to total Akt2 and TBC1D4 from biopsies obtained at the start (B; Basal) and end (I; Insulin) of the hyperinsulinaemic euglycaemic clamp, before and after participants had completed their day shift or night shifts. Data are the mean AE SEM for 5 day shift and 7 night shift participants. *indicates main effect for insulin, P < .05
| Hair follicle cell gene expression
The expression of Per3, Per1, Nr1d1 and Nr1d2 mRNA decreased across the day (P = .001; Figure S5 ) similarly before (day 1) and after (day 7) the day shift and night shifts with no differences (P > .05) between the 2 shifts.
| Sleep
Subjective sleep duration prior to the shifts was similar for both groups ( Figure S6 ). During the simulated shifts, there was a trend (P = .06) for day shift (7.1 AE 0.6 hour) to sleep more than the night shift participants (6.2 AE 1.4 hours). When the nap prior to commencing the night shift was included, the night shift group obtained 1.6 hours less total sleep than the day shift group over the 4 days (P > .05). Actigraph records (objective assessment) were only available for 3 day shifts and 4 night shift participants due to technical difficulties. No difference in sleep duration, latency, per cent sleep efficiency or wakefulness after sleep onset (WASO) was observed between the day and night shift participants (P > .05; Figure S6 , Table S5 ).
| DISCUSSION
This study provides novel evidence showing that a roster of night shifts reduces glucose tolerance and insulin sensitivity in healthy non-shift workers under controlled conditions. Importantly, this effect was observed despite no significant changes in the amount of sleep obtained or the diet in the day and the night shift participants. Thus, these results suggest that alterations in the times of wakefulness, eating and sleep per se may be sufficient for the previously observed decrease in insulin sensitivity in shift workers, independent of changes in circadian rhythm.
There have been few shift work simulation studies that were designed to eliminate or substantially reduce phase shifting as a variable that might explain the metabolic response. Al-Naimi et al 15 assessed the postprandial glucose response to test meals at different times over a day shift and night shift. As expected, 16 the timing of the melatonin rhythm and overall melatonin production were not affected by the sustained wakefulness during that study. However, a significant increase in plasma glucose was observed when participants stayed awake and ate food at night (night shift) compared with the day shift. This change in the glycaemia at night did not change the plasma insulin levels, but it is a clear marker of lower glucose tolerance. Another study by Morris et al 17 imposed 8-hours sleep opportunities between 2300 hour and 0700 hour (control/day shift) or between 1100 hour and 1900 hour (night shift) for 3 days. Peak melatonin levels in the night shift condition were 52% and 59% lower than the day shift condition on days 1 and 3 of the study respectively. Moreover, the time of peak melatonin levels shifted by 1 hour 19 minutes and 3 hour 10 minutes on days 1 and 3 respectively. 17 In the current study, peak melatonin levels were delayed, but more modestly, by approx 1.6 hours between day 3 and day 7 in the night shift group; however, unlike the Morris et al study, we did not sample blood across 24 hours. Both studies found that simulated night shift impaired insulin sensitivity, even though Morris et al used standard test meals to assess insulin sensitivity, while the current study used the gold standard hyperinsulinaemic euglycaemic clamp procedure. Interestingly, during the wake period, the changes in insulin sensitivity Data were compared by 2-way repeated measures ANOVA. *P < .05 vs Pre-night shift were independent of changes in salivary melatonin onset, which is a marker of central rhythmicity or hair follicle cell clock gene mRNA expression which is a marker of peripheral central rhythmicity. In addition, the impairment of insulin sensitivity in the current study was not related to changes in the phosphorylation of the key insulin signalling proteins such as Akt and TBC1D4. [18] [19] [20] Taking all these results together, we suggest that the reduction in insulin sensitivity observed after the night shift work may have been due to insulin resistance in other tissues such as the liver. Further studies using glucose tracers during the hyperinsulinaemic euglycaemic clamp are needed to assess the insulin sensitivity of the liver after night shifts to answer these questions. Mitochondrial function may also play a key role in insulin sensitivity, although whether mitochondrial dysfunction is a cause or consequence of insulin resistance remains controversial.
12,21-25 Interestingly, while circadian misalignment induced by sleep deprivation in mice has been found to impair brain mitochondrial function, 26 the impact of circadian misalignment on this in human skeletal muscle had not previously been examined. In the current study, we measured skeletal muscle protein content and protein phosphorylation rather than gene expression as it provides a better indication of muscle function. To determine whether any reduction in whole-body insulin sensitivity was due, at least in part, to reductions in skeletal muscle insulin signalling, we examined phosphorylation of Akt and TBC1D4 as markers of proximal and distal insulin signalling respectively. PGC1a, which is a master regulator of mitochondrial biogenesis, was measured in case there was a decrease in citrate synthase (CS) activity (an indicator of mitochondrial volume). The mitochondrial complexes were measured as a way, along with CS activity, to determine whether there was a change in mitochondrial volume with night shift that may explain any changes in mitochondrial function. TFAM (mitochondrial transcription factor A) indicates nucleus-mitochondrial interactions that would be of interest if there was a change in CS activity of PGC1a. We also measured UCP3 as it is the main uncoupling protein in skeletal muscle with regards to understanding any changes in mitochondrial function. We found that 4 nights of shift work did not affect skeletal muscle mitochondrial respiration, mitochondrial content based on CS activity or protein expression of PGC1a, TFAM and mitochondrial complexes. Our findings therefore indicate that the decreased insulin sensitivity after night shifts was not due to changes in mitochondrial respiration, volume or biogenesis. On the other hand, an intriguing finding of this study was the decrease in mitochondrial ROS (H 2 O 2 ) emission in the CI+II Leak state following night shifts. Currently, it is F I G U R E 6 Dietary energy intake and total fat and carbohydrate consumption did not differ between groups before and after the night and day shifts respectively. However, subjects in the night shift group consumed less protein during the 4-day shifts than before the start of the study. Summary of the daily dietary intake of energy (A), protein (B), total fat (C), saturated fat (D), available carbohydrate (E) and sugars (F) calculated from 4 days of diet recordings at home before the study and on days 3-6 during the shifts. Data were compared by 2-way repeated measures ANOVA. *P < .05 vs Pre-night shift. Data are the mean AE SEM for 6 day and 8 night shift participants not possible to explain the reason of these intriguing results, but in contrast to the previous literature, recent evidence has shown that physiological levels of ROS generation are required for normal insulin responses 27 . This question needs to be investigated more carefully in future studies, particularly in the context of chronic shift workers. It has been proposed that predominant or additional drivers of poor metabolic health of shift workers may be poor nutrition and in particular altered appetite, increased total energy intake 28 or increased fat and snack intake. 29 Previous shift work simulation studies have imposed strict dietary control on the participants which could in itself alter metabolic function. 30 We provided the participants with individualized ingredients to prepare their own normal meals and snacks in an attempt to make the simulation as close to a real work situation as possible. An interesting consequence of this approach was that day shift participants voluntarily had only a small snack on the first meal opportunity (1030 hour-1100 hour), whereas for the night shift participants, this small meal occurred in the second meal opportunity during their shift (0300 hour to 0330 hour). To what extent this may have contributed to the change in insulin sensitivity observed in this study is not known. The dietary intake of protein was slightly lower during both day and night shifts compared with pre-study levels, but there was no difference in intake of any macronutrients between the day and night shifts. This would suggest that the decrease in insulin sensitivity we report here in the night shift group was not due to altered energy or fat intake. Participants on night shift slept only an average of 25 minutes less per 24 hour period than the day shift participants which totalled 1.6 hour across the whole 4-day period (not statistically significant). This is less than we have observed in the field, where the total sleep obtained on night shifts was 1.7 hours less per night than the 7.4 hours of sleep obtained on days off. 8 In a simulation study similar to that used in the current study, the cumulative sleep debt accrued over 4 night shifts was modest at approx 2.5 hours. 31 This would suggest that although the actigraphic analysis in current study lacked power, sleep debt is unlikely to have had a major impact on glucose metabolism. Despite the novel aspects of this study, the study had some limitations. For instance, the sample size was relatively small, in part due to the challenging nature of the study which required participants undertaking invasive procedures such as several venous cannulations and muscle biopsies while living under controlled conditions in our research facility. While the repeated measures analysis indicated a robust change in insulin sensitivity in the night shift group across the study, but not the day shift group, the study lacked the power to detect a statistically significant change in insulin sensitivity between the day shift and night shift work participants after simulated shift work. In addition, several technical problems meant that the full data set was not available from some of the participants. We chose to use a nonrandomized and non-cross over design in order to match the 2 groups in terms of gender, age, physical activity levels and BMI and to reduce the number of cannulations and muscle biopsies in each participant respectively. Our determination of central and peripheral clocks was based on only partial profiles of salivary melatonin and hair follicle gene expression respectively. This was because as we decided to not collect samples during the participants sleep time, so as to avoid any disturbance on the sleep, which could affect the participant's metabolic responses. Therefore, we do not know for certain that no changes occurred in central and/or peripheral clocks following the night shift. However, despite these limitations, the study was able to demonstrate a significant reduction in insulin sensitivity in the night shift group, with all participants (8/8) being lower after the simulated night shift.
In conclusion, a 4-days roster of simulated night shift work is sufficient to reduce insulin sensitivity by approx 25%, independent of diet or changes in circadian rhythmicity. These results have important implications for chronic shift workers who not only have changes in their work cycles but also tend to sleep less and have unbalanced diets, both of which can reduce insulin sensitivity. Our results provide important mechanistic understanding of the negative effects of shift work on glucose metabolism and insulin action that result in increased rates of T2D in chronic shift workers.
| MATERIALS AND METHODS

| Participants
Seventeen healthy non-smokers (9 females, 8 males; age 25.6 AE 5.1 years; Mean AE SD) subjects completed this study in an environmentally controlled facility within Victoria University (Melbourne, Australia). Participants were eligible to take part in the study if they had intermediate morningness/eveningness chronotype scores, 32 and an intermediate melatonin onset measurement (assessed between 1800 hour and 2200 hour) collected under a light intensity of <50 lux. Participants completed physical activity (7 days) and dietary records (4 days) before entering the study and during the study. In addition, during the study, the heart rate of the participants was recorded during the awake period (data not shown). Participants were also provided with all food and drinks during the study in agreement with the information provided in the dietary records as well as the participants' personal preferences. Participants were excluded from participation if they had diabetes, currently smoked, were taking any medications affecting muscle or liver metabolism, exhibited disturbed sleep patterns, performed more than 1 hour of exercise per day, were current shift workers or who had travelled overseas within the last 2 months. Participants were assigned to either a simulated day shift group or a simulated night shift group, balanced for age, body weight, height, gender and physical activity. After an explanation of the experimental procedures, all participants gave their written informed consent before commencing the study which was approved by the Human Ethics Committees of Victoria University and the University of Adelaide (Australia).
| Experimental protocol
The study was conducted in an environmentally controlled facility within the Institute of Sport, Exercise and Active Living (ISEAL) at Victoria University. On 4 consecutive days, the control day shift group were assigned to have a 9-hour sleep opportunity between 2200 hour and 0700 hour, while the night shift group was assigned a 9-hours sleep opportunity between 0800 hour and 1700 hour ( Figure 1 ). When 2 participants were studied simultaneously, they were allocated to separate rooms and were assigned to the same shift. Participants recorded their dietary intake for 4 days before entering the laboratory using a semiquantitative 4-day weighed food diary and were provided with food and beverages similar to this throughout the study as changing the diet can have its own effects on insulin sensitivity. The study was completed in 2 stages with an intervening break for operational reasons.
| Stage 1
After arriving at the research facility, the participants prepared their dinner at 2000 hour and then were confined to their bed in a completely darkened room from 2200 hour until 0700 hour to sleep. Then, after an overnight fast, an intravenous glucose tolerance test (IVGTT, see below) commenced at~0830 hour. Participants stayed for the rest of the day in the research facility. A meal opportunity was provided after the IVGTT (~12:30 hour) and again at 1730 hour and 2000 hour. Participants could leave the facility for 30 minutes each day (1730 hour-1800 hour) and were able to undertake low to moderate intensity walking, but not exercise training. Participant heart rates were recorded during the awake period (data not shown). Saliva was collected at 1800 hour, 1900 hour, 2000 hour, 2100 hour and 2200 hour, after which participants were confined to their bedrooms to sleep. The next morning (Day 2) after an overnight fast, muscle biopsies (see below) were collected before and after a hyperinsulinaemic euglycaemic clamp (HEC, see below). All participants performed the tests at the same time of day (AE1 hour). Upon completing the second biopsy, the participants were free to leave the research facility.
| Stage 2
This stage began 2.6 AE 1.2 days and 1.8 AE 0.5 days after Stage 1 for the day shift and night shift participants respectively. Participants returned to the facility at approx 1400 hour, and those assigned to the night shift were given a nap opportunity between 1500 hour and 1800 hour. Hourly saliva sampling commenced at 1800 hour, with those on the day shift ceasing sampling at 2200 hour and recommencing sampling at 0700 hour, 0800 hour and 0900 hour. Those on the night shift continued hourly saliva collection until the commencement of their sleep opportunity at 0800 hour. The maximum light intensity recorded in the night shift was 290 lux. Participants spent their time in the facility completing questionnaires, using a driving simulator, watching TV, playing games, reading, studying or cooking. All these activities kept them active; however, they were not permitted to engage in any formal exercise. The day shift group maintained their sleep opportunity between 2200 hour and 0700 hour throughout the study. The night shift participants had 3 consecutive days of sleep opportunity between 0800 hour and 1700 hour, followed by a transition sleep opportunity from 0800 hour to 1500 hour on Day 6 during the last 2 days of the stage 2 (Day 7 and 8) to help them return to night sleep (2200 hour to 0700 hour). On Day 7 and Day 8 after an overnight fast, both groups were subjected to the IVGTT and muscle biopsies/HEC as above (Figure 1 ). To simulate commuting to work, during stage 2, participants left the facility and were encouraged to walk outside (but not engage in moderate or high intensity exercise) for 30 minutes between 0800 hour-0830 hour and 0700 hour-0730 hour for the day shift and night shift groups, respectively, and again in the afternoon between 1730 hour and 1800 hour for both groups. Adherence to these activity restrictions was monitored with a heart rate monitor. Both groups were assigned 5 eating opportunities. For the day shift, these were 0730 hour-0800 hour, 1030 hour-1100 hour, 1300 hour-1400 hour, 1730 hour-1800 hour and 2000 hour-2100 hour. For the night shift, they were 1700 hour-1730 hour, 2000 hour-2100 hour, 2400 hour-0030 hour, 0300 hour-0330 hour an 0600 hour-0700 hour. No food or beverages (except water) were allowed outside of these times. No caffeinated beverages were allowed. 
| Muscle biopsies
Vastus lateralis muscle biopsies (approx 150 mg) were obtained by a qualified medical doctor before and immediately after each HEC from separate incisions separated bỹ 1 cm. The site of the biopsies was anaesthetized using lignocaine without adrenaline. Samples were used to assess mitochondrial respiration on fresh tissue and the rest snap frozen in liquid nitrogen and then stored at À80°C.
| Western blot analysis
Protein (4-6 lg per well) along with a 4-point calibration curve was separated by gel electrophoresis at 150 V for 75 minutes for OXPHOS proteins on 4-20% Criterion StainFree precast gels (Bio-Rad) and for all other proteins 200 V for 45 minutes with 4-15% or 7.5% Criterion Stain-Free precast gels (Bio-Rad). Gels were UV activated for total protein visualization on the membrane after transfer by ChemiDocTM MP Imaging System (Bio-Rad). The membrane was blocked with 5% (w/v) skim milk powder dissolved in Trisbuffered saline containing 0.1% Tween-20 (TBST) at room temperature for 1 hour. The primary antibodies described below were diluted in 5% (w/v) BSA and 0.1% sodium azide in TBST or blocking buffer and incubated overnight at 4°C. The next day following a 1-hour incubation with anti-mouse or anti-rabbit HRP secondary antibodies and a series of washes in TBST, chemiluminescent signal was developed (SuperSignal West Femto, Pierce) and imaged by the ChemiDocTM MP Imaging System (Bio-Rad).
| Mitochondria respirometry
Skeletal muscle fibres were permeabilized after collection by agitation with saponin (0.005% wt/vol) for 30 
| Dietary intake
Dietary records were used to provide the subjects with similar food and drinks during the study. Additionally, participants provided semiquantitative food diaries during the study that were analysed using a computerized database (Foodworks 7 Professional Edition, Xyris Software, Australia).
| Saliva melatonin
To examine central circadian rhythmicity, saliva was collected using Salivettes (Sarstedt Australia, Technology Park, South Australia) and melatonin analyses were performed by radioimmunoassay 33 (Buhlmann Laboratories, Allschwil, Switzerland). Onset of melatonin secretion (MOn) was defined as the time of day that the melatonin concentration exceeded 10 pmol L À1 . In cases where the levels had not exceeded 10 pmol L À1 by the time sampling ceased, the onset was recorded as occurring 1 hour later than the last sample collection. Similarly, for determining the offset time (MOff), this was the time that the melatonin decreased below 10 pmol L À1 ; if it was already below 10 pmol L À1 before the first sample of the morning, it was deemed to have occurred 1 hour earlier than that time.
| Hair follicle cell mRNA
Hair samples (~20) obtained from different regions of the scalp at 0800 hour, 1200 hour, 1600 hour and 2000 hour on day 1 and 7 were placed into tubes containing 100 lL of lysis buffer and stored at À80°C. 34 The RNA was extracted and DNAs treated using RNAqueous Micro Kits (Life Technologies Australia, Mulgrave, Victoria). RNA was reverse transcribed to cDNA using Turbo Superscript III (Life Technologies), random hexamers (GeneWorks, Thebarton, SA) and DNTPs (GE Healthcare, North Sydney, NSW). Gene expression was quantified using Power SYBR Green master mix and a 7500 Real Time PCR System (Life Technologies). All primers used (Table S1) were sourced from GeneWorks. Analysis of Nr1d1, Nr1d2, Per1 and Per3 mRNA expression was normalized to the expression of b-actin using the ÀDDCt method. 35 
| Sleep
Participants wore an Actiwatch activity monitor (Philips Respironics, Bend, OR) over the 4-7 days before the experimental period to ensure the required sleep schedule was maintained and during the study. However, due to equipment failure, objective sleep information was available for only 7 of the 17 participants (3 day shift and 4 night shift).
Each participant, however, provided in a sleep diary the estimated time of sleep onset and wake up times, from which subjective sleep duration was calculated.
| Hormone analysis
Plasma insulin was analysed by double antibody RIA (HI-14K, EMD Millipore, Billerica, Massachusetts, USA). Plasma leptin was analysed in baseline samples for the IVGTT and HEC by double antibody RIA (HL-81K, EMD Millipore).
| Statistical analysis
Area under the glucose and insulin curves during the IVGTT was calculated using GraphPad Prism 7. All data were analysed by repeated measures 2-way ANOVA (IBM SPSS Statistics version 20). When the ANOVA revealed a significant interaction, specific differences were identified using a least significant difference post hoc test. Percentage change between pre-and post-shift periods for the day and night shift groups was compared using paired samples t tests. Actigraphic sleep data were first analysed using Philips Respironics Actiware software (version 6.0) and then repeated measures ANOVA across the 3-day lead-in and the 4 days of simulated day or night shifts. Friedman's nonparametric analysis of variance was used to determine whether the time of onset varied within the groups across the duration of the study. Friedman's nonparametric analysis of variance was used to determine whether the time of onset varied within the groups across the duration of the study. Data are presented as means AE SEM. A P value of ≤ .05 was considered significant.
